Envista Holdings (NVST) Earnings: Q3 2026 Results and Next Report Date

The quarter ended October 2, 2026 and Envista published the results on November 4, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Envista reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted diluted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Q3 2026 GAAP results include a $428.1 million non-cash gain from releasing cumulative foreign currency translation adjustments when Envista dissolved certain legal entities. Envista says it added $2.62 to diluted EPS before tax effects and is excluded from adjusted EPS.
• Envista's fiscal quarters end on a Friday: Q3 2026 ended October 2, 2026 and Q3 2025 ended September 26, 2025.

Source: Envista Q3 2026 results, November 4, 2026. Also in the Form 10-Q for the quarter ended October 2, 2026. Figures as reported; checked against the release on November 10, 2026.

How Envista splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Envista's Specialty Products & Technologies revenue was $444 million in Q3 2026, up 3% from $432 million in Q3 2025, 64% of total revenue.
• Envista's Equipment & Consumables revenue was $248 million in Q3 2026, up 4% from $238 million in Q3 2025, 36% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, Envista said:

“Core Sales Growth 3.75% to 4.25%”

“Adjusted EBITDA Growth 12.5% to 14%”

“Adjusted Diluted Earnings Per Share $1.54 to $1.58”

“Please note, we do not provide forward-looking estimates on a GAAP basis as certain information is not available and cannot be reasonably estimated.”

Source: Envista Q3 2026 release, Nov 4, 2026.

This is the company's own guidance as of Nov 4, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the NVST forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP sales and diluted EPS, each as first reported in that quarter's release.

Envista's next report is expected around February 3, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 4, 2026

Envista is a dental products company whose brands include Nobel Biocare, Ormco, DEXIS and Kerr. Sales were $691.5 million in Q3 2026, up 3.2% from $669.9 million, with core sales growth of 2.7%, which excludes acquisitions and currency. Specialty Products & Technologies brought in $443.7 million and Equipment & Consumables $247.8 million. (Envista Q3 2026 release, Nov 4, 2026; Envista Form 10-Q, Q3 2026, Nov 4, 2026)

Envista's Specialty Products & Technologies segment sells dental implant systems, regenerative solutions, prosthetics and treatment software, plus orthodontic brackets, aligners, lab products and loupes, mostly direct: 84% of its 2025 sales were direct sales. Equipment & Consumables sells digital imaging systems, endodontic systems, restorative materials, burs, impression materials, bonding agents and infection prevention products, about 89% through channel partners in 2025. One distributor, Henry Schein, accounted for about 12% of Envista's 2025 sales. (Envista Form 10-K, 2025, Feb 12, 2026)

Price did more than volume in the quarter. Envista said a 1.8% increase in sales price and a 0.9% increase in volume drove sales. Specialty Products & Technologies core sales grew 2.0%, and Equipment & Consumables 4.1%, the latter on a 2.4% price increase and 1.7% higher volume. The February 2026 acquisition of Versah, maker of Densah burs, added 0.5% to total sales growth. (Envista Form 10-Q, Q3 2026, Nov 4, 2026; Envista Q3 2026 release, Nov 4, 2026)

By region, North America was $360.7 million of Envista's Q3 2026 sales, Western Europe $142.9 million, emerging markets $155.8 million and other developed markets $32.1 million. Core sales in developed markets grew 3.5% and in emerging markets 0.4%, despite lower sales in China. In Specialty Products & Technologies, emerging markets core sales fell 2.0%, driven by China. (Envista Form 10-Q, Q3 2026, Nov 4, 2026)

Envista's GAAP diluted EPS of $3.11 is far above its adjusted diluted EPS of $0.40 because of a one-time $428.1 million gain from releasing cumulative foreign currency translation adjustments when it dissolved certain legal entities. Envista says the gain was worth $2.62 of diluted EPS before tax effects and had no cash impact. Adjusted EPS also excludes amortization of acquisition-related intangibles ($0.09), restructuring costs ($0.05) and tariff refunds, which added $15.6 million to GAAP gross profit. (Envista Q3 2026 release, Nov 4, 2026)

The year-ago GAAP loss of $0.18 per share came mainly from tax: Envista's income tax expense was $80.2 million in Q3 2025, an effective rate of 160.7%, against a benefit of $8.1 million and a rate of (1.6)% in Q3 2026. Discrete tax adjustments added $0.37 to the year-ago adjusted EPS of $0.32. (Envista Q3 2026 release, Nov 4, 2026; Envista Form 10-Q, Q3 2026, Nov 4, 2026)

Envista's diluted share count fell to 163.4 million from 167.5 million on an adjusted basis. It repurchased 386 thousand shares for about $10 million in the quarter and had about $273 million left under its repurchase program at quarter end. (Envista Q3 2026 release, Nov 4, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Envista gives full-year guidance on a non-GAAP basis only. After Q3 2026 it raised its 2026 adjusted diluted EPS outlook to $1.54 to $1.58, from $1.50 to $1.55, and narrowed core sales growth to 3.75% to 4.25%, from 3.5% to 4.5%. It expects adjusted EBITDA growth of 12.5% to 14% and free cash flow conversion of about 100%. (Envista Q3 2026 release, Nov 4, 2026)

Envista's adjusted diluted EPS for the first nine months of 2026 was $1.16, against $0.82 a year earlier. CEO Paul Keel said the year-to-date progress gave Envista the confidence to raise its full-year earnings guidance again. Envista does not give a separate fourth-quarter outlook. (Envista Q3 2026 release, Nov 4, 2026)

A consensus figure is the average of the models published by the analysts who cover Envista, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Envista's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning NVST is on is NVST a buy or a sell?, what analysts expect next is on the NVST forecast, and what the company does is on the Envista Holdings (NVST) stock page.

Every number on this page can be traced to a document Envista published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.